The Impact of Azithromycin on Surgical Site Infection Rates

Phase 4

• Conditions: Surgical wound infection; Endometritis; Maternal Sepsis; Infection - Studies of infection and infectious agents; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12619000018112
• Lead Sponsor: Obstetrics & Gynaecology Department, Redland Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-01-09
• Last Update Posted: 28 January 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 385

Inclusion Criteria

Singleton pregnancy AND
Equal to or more than 32 weeks pregnant AND
Emergency lower segment Cesarean section (LSCS) either in labour (defined as regular painful contractions AND progressive cervical dilatation of at least 4cm OR Rupture of Membranes >4 hours OR meeting both criteria)

Exclusion Criteria

Elective lower segment Caesar section OR
Azithromycin/ Iodine/ Cefazolin allergy OR
Inability to provide or declined consent OR
Multiple pregnancy OR
On antibiotics for any other reasons within 7 days of labour OR
Azithromycin/ Iodine/ Cefazolin medically contraindicated

Study & Design

• Study Type: Interventional
• Study Design: Not specified